WTO to intensify Covid vaccine supply negotiations
World Trade Organization (WTO) member states have taken a step closer toward boosting Covid-19 vaccine supply to poorer countries.
This content was published on
2 minutes
Keystone-SDA/Reuters/AP/sb
South Africa and India, supported by many emerging countries, have been pushing for a temporary waiver of intellectual property rights on vaccines and other treatments. This could allow local manufacturers to produce Covid shots and other products.
On Wednesday, following a two-day meeting, a WTO panel agreed to start a “text-based process” to bring together proposals about improving efforts to get vaccines to poorer countries via the Geneva-based WTO’s complex system of rules.
New, informal talks will start on June 17 among members of the panel, with a view to pulling together a report for a meeting of WTO ambassadors on July 21-22.
More
More
The WTO’s long struggle to reach vaccine equity
This content was published on
The World Trade Organization has begun discussions on a worldwide Covid-19 vaccine roadmap to ensure they reach everyone, in every country.
“This is a major breakthrough – after eight months of stalling,” Leena Menghany, global IP adviser for medical aid group MSF, told Reuters. MSF backs a waiver.
Wealthy nations, many home to large pharmaceutical firms, have dug their heels in arguing that a waiver would not boost production and could undermine future research and development on vaccines and therapeutics.
The European Union has presented a plan, backed by Britain, Switzerland and South Korea, that instead seeks to limit export restrictions, expand production and facilitate the use of compulsory licences.
During the two-day meeting in Geneva this week, Switzerland rejected the proposal to lift intellectual property rights for at least three years. It warned that such a move would not provide any future protection for manufacturers. This would thus reduce states’ abilities to prepare for the next pandemic, it argued.
More
More
WHO aims to boost global vaccine production, but no agreement on patents
This content was published on
The resolution approved at this year’s World Health Assembly falls short of agreement on how to boost vaccine access.
First large-scale alpine solar plant approved in Switzerland
This content was published on
The approval was met with satisfaction by the project's organisers, but it also brings with it a certain amount of pressure.
Medieval squirrels may have ‘helped spread leprosy’
This content was published on
An examination of squirrel remains in the United Kingdom has opened up interesting questions and possibilities in terms of the history of the disease.
Swiss money laundering office registers record number of reports
This content was published on
The Money Laundering Reporting Office Switzerland (MROS) registered a record number of reports of suspicious activity last year.
Two teens accused of planning terror attack released from custody
This content was published on
The Schaffhausen judiciary has released the two teenagers from custody who allegedly planned bomb attacks in Switzerland.
This content was published on
The World Trade Organization has begun discussions on a worldwide Covid-19 vaccine roadmap to ensure they reach everyone, in every country.
Calls intensify for Big Pharma to break monopolies on Covid-19 vaccines
This content was published on
Pressure is mounting to suspend intellectual property rules to help vaccines reach more people. Can the WTO find a solution?
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.